ArticleFrontiers in pharmacology2022

Pan-cancer analysis suggests histocompatibility minor 13 is an unfavorable prognostic biomarker promoting cell proliferation, migration, and invasion in hepatocellular carcinoma.

Jun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.